These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 18555464

  • 1. High dose chemotherapy and autologous stem cell transplantation in patients with multiple myeloma: the experience of a single haematological unit.
    Papanikolaou X, Maltezas D, Repousis P, Athanassopoulos A, Alexia S, Megalakaki K, Kotsopoulou M, Mitsouli-Mentzikof C.
    J BUON; 2008; 13(2):193-7. PubMed ID: 18555464
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
    Lahuerta JJ, Mateos MV, Martínez-López J, Rosiñol L, Sureda A, de la Rubia J, García-Laraña J, Martínez-Martínez R, Hernández-García MT, Carrera D, Besalduch J, de Arriba F, Ribera JM, Escoda L, Hernández-Ruiz B, García-Frade J, Rivas-González C, Alegre A, Bladé J, San Miguel JF.
    J Clin Oncol; 2008 Dec 10; 26(35):5775-82. PubMed ID: 19001321
    [Abstract] [Full Text] [Related]

  • 6. Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma.
    Abraham R, Chen C, Tsang R, Simpson D, Murray C, Davidson M, Meharchand J, Sutton DM, Crump RM, Keating A, Stewart AK.
    Bone Marrow Transplant; 1999 Dec 10; 24(12):1291-7. PubMed ID: 10627637
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
    Schetelig J, Fetscher S, Reichle A, Berdel WE, Beguin Y, Brunet S, Caballero D, Majolino I, Hagberg H, Johnsen HE, Kimby E, Montserrat E, Stewart D, Copplestone A, Rösler W, Pavel J, Kingreen D, Siegert W.
    Haematologica; 2003 Nov 10; 88(11):1272-8. PubMed ID: 14607756
    [Abstract] [Full Text] [Related]

  • 9. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.
    Natl Med J India; 2003 Nov 10; 16(1):16-21. PubMed ID: 12715951
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
    Papajik T, Raida L, Faber E, Vondrakova J, Prochazka V, Kubova Z, Skoumalova I, Jarosova M, M LK, Paucek B, Myslivecek M, Neoral C, Oral I, Jarkovsky J, Dusek L, Indrak K.
    Neoplasma; 2008 Nov 10; 55(3):215-21. PubMed ID: 18348654
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined submyeloablative and myeloablative dose intense melphalan results in satisfactory responses with acceptable toxicity in patients with multiple myeloma.
    Novitzky N, Thomson J, Thomas V, du Toit C, Mohamed Z, McDonald A.
    Biol Blood Marrow Transplant; 2010 Oct 10; 16(10):1402-10. PubMed ID: 20385248
    [Abstract] [Full Text] [Related]

  • 14. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E, Apperley JF, Samson D, Giles C, Crawley C, Kanfer E, Olavarria E, Goldman JM, Rahemtulla A.
    Bone Marrow Transplant; 2003 Feb 10; 31(3):163-70. PubMed ID: 12621476
    [Abstract] [Full Text] [Related]

  • 15. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL, De Giorgi U, Ferrari B, Castagna L, Alloisio M, Marangolo M, Rosti G, Santoro A.
    Biol Blood Marrow Transplant; 2006 Oct 10; 12(10):1085-91. PubMed ID: 17084372
    [Abstract] [Full Text] [Related]

  • 16. ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
    Offidani M, Leoni P, Corvatta L, Polloni C, Gentili S, Savini A, Alesiani F, Brunori M, Catarini M, Visani G, Samori A, Burattini M, Centurioni R, Montanari M, Fraticelli P, Ruggieri M, Falcioni S, Galieni P.
    Eur J Haematol; 2010 Jun 10; 84(6):474-83. PubMed ID: 20331733
    [Abstract] [Full Text] [Related]

  • 17. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer.
    Tallman MS, Rademaker AW, Jahnke L, Brown SG, Bauman A, Mangan C, Kelly C, Rubin H, Kies MS, Shaw J, Kiel K, Gordon LI, Gradishar WJ, Winter JN.
    Bone Marrow Transplant; 1997 Nov 10; 20(9):721-9. PubMed ID: 9384473
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma patients--single center experience].
    Piatkowska-Jakubas B, Wolska-Smoleń T, Mensah-Glanowska P, Hawrylecka D, Szostek M, Walter Z, Skotnicki AB.
    Przegl Lek; 2011 Nov 10; 68(2):78-81. PubMed ID: 21751514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.